Trial Profile
Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Apr 2016
Price :
$35
*
At a glance
- Drugs Trandolapril (Primary)
- Indications Coronary artery disease; Sudden death
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms PEACE
- 16 Dec 2011 Biomarker substudy results published in Circulation.
- 18 Sep 2007 The expected completion date for this trial is now 1 Jun 2005.
- 22 Oct 2005 New trial record.